T-DM1 targets HER2, is internalized, and releases DM1, which binds beta-tubulin to disrupt microtubules, causing mitotic arrest and cell death. Cells expressing beta-tubulin alone are not selectively killed; only HER2+ cells receive the cytotoxic payload.